Importantly, isotype analyses have indicated that patients developing severe COVID-19 present a significantly higher IgM and IgA response, while individuals with mild disease show an immunodominant IgG profile with greater immunological diversity, antibody class switching, and higher affinity, especially to the prefusion spike protein [26]. The gene discussed is CD79A; the disease is COVID-19.